Product Reports Resources Pricing Login Book a demo

Suzhou Saipu Biotechnology

Biotech & Life Sciences · Suzhou Shi, China · Founded 2018

Focused on developing, manufacturing and selling high-end plasticware to life science MoreLess

Established in 2018 within the Suzhou Industrial Park, Suzhou Saipu Biotechnology Co., Ltd. (CellPro) operates as a manufacturer and solutions provider of high-end biomedical consumables. The company has established itself within China's life sciences sector, focusing on the development, production, and sale of specialized plasticware.

CellPro's business model is centered on manufacturing and supplying a wide array of products while also offering customized services. Revenue is generated through the sale of its extensive product portfolio and by providing bespoke solutions, from mold design and manufacturing to large-scale production for biomedical firms. The company serves a global clientele across more than 50 countries in sectors such as molecular diagnostics, biopharmaceuticals, cell and gene therapy, and clinical medicine.

The firm's product lineup includes over 900 SKUs across categories like liquid handling, cell culture, molecular detection, sample storage, and immunoassay. Specific products include pipette tips, centrifuge tubes, PCR plates, petri dishes, and blood collection tubes. CellPro differentiates itself through its integrated capabilities, housing a high-precision mold R&D center and advanced production facilities. The company operates over 140 automated production lines within a 50,000 m² facility, which includes extensive ISO Class 7 and 8 cleanrooms. This vertical integration allows for control over the entire process from R&D and mold design to final production and biological verification.

Since its inception, CellPro has achieved significant milestones, securing over 80 patents and receiving recognition as a National High-tech Enterprise and a potential "unicorn" in China. The company is venture capital-backed, with investors including CICC Capital and YuanBio Venture Capital. Positioned within the burgeoning biotech hub of Suzhou, which aims to become a world-class 'Pharma Valley', CellPro is contributing to the region's rapid growth in the life sciences industry.

Keywords: biomedical consumables, life science supplies, lab plasticware, cell culture products, molecular diagnosis consumables, customized lab services, pipette tips manufacturer, centrifuge tubes supplier, PCR plates, immunoassay plates, Suzhou biotechnology, biopharmaceutical manufacturing, gene therapy supplies, clinical diagnostics, automated lab production, ISO 13485 certified, CE-MDR certified, high-tech enterprise, liquid handling solutions, sample storage systems

Company overview

Suzhou Saipu Biotechnology company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2018
Headquarters
Suzhou Shi, China
Employees
10
Open positions
None listed
Dealroom signal
26.0
client focusb2btechnologyDeep Techsub industryBioTechnologysub industryMedical Devicesbusiness modelManufacturingindustryHealthsectorBiotechnologysectorBiotech and PharmasectorTechbiosectorHard TechsectorbiomanufacturingsectorDT and LSsectorscience-based

Valuation & funding

Suzhou Saipu Biotechnology funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BEquity / VC Sep 2022 $28M $110M Oriza Holdings · CICC · Hangzhou Oriental Fortune Asset Management · China Singapore Suzhou Industrial Park Ventures
Showing 1 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 10
2025 10
2024 11
2023 11
2022 15
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Suzhou Saipu Biotechnology website traffic

Latest recorded traffic for Suzhou Saipu Biotechnology is 360 monthly website visits, down 50% over the last three months. Suzhou Saipu Biotechnology's team grew 0% over the past year.

Latest monthly visits360 3-month web change-50% 1-year team growth0%
Monthly website visits32 observations · Oct 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Suzhou Saipu Biotechnology compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Suzhou Saipu Biotechnology's talent

Book a demo to see the people
Employees 10 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

9 investors on Suzhou Saipu Biotechnology's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 9 investors entered at this stage
Yuansheng BioVenture
Oriza Holdings
CICC
Hangzhou Oriental Fortune Asset Management
China Singapore Suzhou Industrial Park Ventures
Suzhou Shunrong Investment Management
River Head Capital
Xiamen Venture Capital
Gallop Capital

Global footprint

Where Suzhou Saipu Biotechnology has talent and traffic

Workforce by country
2 countries with
team presence
🇨🇳 China77.8%
🇦🇪 United Arab Emirates11.1%
2 countries shown

In the news

Latest news about Suzhou Saipu Biotechnology

Recent press, funding announcements, and product moves mentioning Suzhou Saipu Biotechnology — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Suzhou Saipu Biotechnology

An AI-synthesized read of the highest-engagement posts about Suzhou Saipu Biotechnology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Suzhou Saipu Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.